Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium

Nicola S Meagher & Paul D P Pharoah et al.

Abstract

Limited estimates exist on risk factors for epithelial ovarian cancer (EOC) in Asian, Hispanic, and Native Hawaiian/Pacific Islander women. Participants in this study included 1734 Asian (n = 785 case and 949 control participants), 266 Native Hawaiian/Pacific Islander (n = 99 case and 167 control participants), 1149 Hispanic (n = 505 case and 644 control participants), and 24 189 White (n = 9981 case and 14 208 control participants) from 11 studies in the Ovarian Cancer Association Consortium. Logistic regression models estimated odds ratios (ORs) and 95% CIs for risk associations by race and ethnicity. Heterogeneity in EOC risk associations by race and ethnicity (P ≤ .02) was observed for oral contraceptive (OC) use, parity, tubal ligation, and smoking. We observed inverse associations with EOC risk for OC use and parity across all groups; associations were strongest in Native Hawaiian/Pacific Islander and Asian women. The inverse association for tubal ligation with risk was most pronounced for Native Hawaiian/Pacific Islander participants (odds ratio (OR) = 0.25; 95% CI, 0.13-0.48) compared with Asian and White participants (OR = 0.68 [95% CI, 0.51-0.90] and OR = 0.78 [95% CI, 0.73-0.85], respectively). Differences in EOC risk factor associations were observed across racial and ethnic groups, which could be due, in part, to varying prevalence of EOC histotypes. Inclusion of greater diversity in future studies is essential to inform prevention strategies.

This article is part of a Special Collection on Gynecological Cancers.

Funding
SURVEILLANCE EPIDEMIOLOGY & END RESULTS PROGRAMNHMRC Investigator Grant GNT1173346Ovarian Cancer and Gonadotropin SignalingDana-Farber/Harvard Cancer Center Ovarian Cancer SPOREPathologyOvarian Cancer and Gonadotropin SignalingGenes, Hormones & Environment in an Ovarian Cancer ModelThe Molecular Epidemiology Of Ovarian CancerRelating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and RiskDepartment of Defense Ovarian Cancer Research Program, Ovarian Cancer Academy Early Career Investigator Award Grant OC200236Phytoestrogens, alcohol, and endometrial cancer riskNorthern California Cooperative Family Registry for Breast CancerU.S. Department of Defense (United States Department of Defense) Grant W81XWH-10-1-02802Epidemiology of Ovarian Cancer:New HypothesesOvarian Cancer Research Fund Grant PPD/RPCI.07NCI NIH HHS Grant R01-CA83918National Health and Medical Research Council of Australia Grant 400281California Cancer Research Program Grant 2II0200The Progesterone Receptor Gene and Ovarian Cancer RiskCollaborative Genetic Study of Ovarian Cancer RiskObesity in ovarian cancer prognosisHereditary Breast Cancer: Genetic and Molecular StudiesMedical Research and Materiel Command Grant DAMD17-01-1-0729National Institutes of Health (NIH) Grant R01-CA87538Cancer Councils of New South Wales, Victoria, Queensland, South Australia, and Tasmania; and Cancer Foundation of Western Australia FundingOvarian Cancer Australia and the Peter MacCallum Foundation FundingCancer Research Training and Education CoordinationESTROGEN, DIET, GENETICS AND ENDOMETRIAL CANCERHormone Therapy and Risk of Ovarian CancerSURVEILLANCE EPIDEMIOLOGY AND END RESULTSLon V Smith Foundation Grant LVS-39420Cancer Biology Research ProgramSteroid Hormone Genes and Ovarian Cancer RiskProject 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian CancerPathologyCalifornia Cancer Research Program Grant 00-01389 V-20170National Cancer Institute Grant R01-CA83918National Cancer Institute Grant NIH-K22-CA138563National Cancer Institute Grant NIH-K07 CA095666Department of Defense Grant DAMD17-02-1-0666The Progesterone Receptor Gene and Ovarian Cancer RiskNIH Grant R01CA61132NIH Grant P30CA14089SURVEILLANCE EPIDEMIOLOGY AND END RESULTSNIH Grant N01PC67010NIH Grant P01CA17054Hereditary Breast Cancer: Genetic and Molecular StudiesNorthern California Cooperative Family Registry for Breast CancerGENETIC EPIDEMIOLOGY OF OVARIAN CANCERDana-Farber/Harvard Cancer Center Ovarian Cancer SPORENIH Grant R01-CA54419NIH Grant R01-CA76016Cancer Genetic Network (CGN)In vitro and In Vivo screening of chemopreventive agentsNational Institutes of Health Grant R01-CA58598Steroid Hormone Genes and Ovarian Cancer RiskNational Health and Medical Research Council of Australia Grant 400413National Health and Medical Research Council of Australia Grant 199600The Molecular Epidemiology Of Ovarian Cancer

NCI NIH HHS

N01 PC067010

NIH HHS

R03CA115195

NCI NIH HHS

P50 CA105009

NCI NIH HHS

P30 CA008748

NCI NIH HHS

R03 CA115195

NCI NIH HHS

R01 CA054419

NCI NIH HHS

R01 CA076016

NCI NIH HHS

R01 CA248288

NCI NIH HHS

U01 CA069417

NCI NIH HHS

R01 CA087538

NCI NIH HHS

R03 CA113148

NCI NIH HHS

R01 CA058598

NCI NIH HHS

K22 CA138563

NCI NIH HHS

R01 CA058860

NCI NIH HHS

P30 CA014089

NCI NIH HHS

R01 CA083918

NCI NIH HHS

P01 CA017054

NCI NIH HHS

N01 CN025403

NCI NIH HHS

P30 CA071789

NCI NIH HHS

R01 CA112523

NCI NIH HHS

P50 CA136393

NIH/NCI

P30 CA008748

NIH

R03CA115195

NIH

R03CA113148

NIH

N01CN025403

NIH

R01-CA058860

NIH

U01 CA069417

NIH

U01CA071966

NIH

P50-CA105009

NIH

P50 CA136393

NIH

N01-PC-67001

NIH

N01-CN-55424

National Institutes of Health

R01-CA112523